Literature DB >> 1715310

The fragile X mutation does not have any major effect on the expression of the hypoxanthine phosphoribosyltransferase (HPRT) locus in human fibroblasts.

A M Steen1, S Marcus, S Sahlén, K B Nielsen, B Lambert.   

Abstract

The possible influence of the fragile X mutation at Xq27 on the expression of the neighbouring gene (at Xq26) for hypoxanthine phosphoribosyl transferase (HPRT) was studied by determination of the levels of HPRT-RNA and HPRT enzyme activity in fibroblast cell cultures from 7 fragile X patients. These levels were lower (although not statistically significantly lower) than in normal fibroblast cultures. Hence, these data do not support the notion of a major effect of the fragile X mutation on the expression of the HPRT gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715310     DOI: 10.1007/bf00197177

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  The spontaneous azaguanine-resistant mutants of diploid human fibroblasts.

Authors:  R DeMars; K R Held
Journal:  Humangenetik       Date:  1972

Review 2.  Fragile X syndrome: a unique mutation in man.

Authors:  R L Nussbaum; D H Ledbetter
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

3.  Studies on hypoxanthine-guanine phosphoribosyltransferase in fibroblasts from patients with the Lesch-Nyhan syndrome. Evidence for genetic heterogeneity.

Authors:  W N Kelley; J C Meade
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

4.  Levels of hypoxanthine phosphoribosyltransferase RNA in human cells.

Authors:  A M Steen; H Luthman; D Hellgren; B Lambert
Journal:  Exp Cell Res       Date:  1990-02       Impact factor: 3.905

5.  Expression of the hypoxanthine phosphoribosyl transferase gene in resting and growth-stimulated human lymphocytes.

Authors:  A M Steen; S Sahlén; B Lambert
Journal:  Biochim Biophys Acta       Date:  1991-01-17

6.  Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.

Authors:  K B Nielsen; N Tommerup
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X.

Authors:  K B Nielsen; N Tommerup; H Poulsen; P Jacobsen; B Beck; M Mikkelsen
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Fragile X syndrome: search for phenotypic manifestations at loci for hypoxanthine phosphoribosyltransferase and glucose-6-phosphate dehydrogenase.

Authors:  C Mareni; B R Migeon
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

9.  Proposed mechanism of inheritance and expression of the human fragile-X syndrome of mental retardation.

Authors:  C D Laird
Journal:  Genetics       Date:  1987-11       Impact factor: 4.562

  9 in total
  1 in total

1.  Mutation analysis and prenatal diagnosis in a Lesch-Nyhan family showing non-random X-inactivation interfering with carrier detection tests.

Authors:  S Marcus; A M Steen; B Andersson; B Lambert; U Kristoffersson; U Francke
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.